The global helicobacter pylori diagnostics market revenue was around US$ 581.9 million in 2023 and is estimated to reach US$ 926.3 million by 2032, growing at a compound annual growth rate (CAGR) of 5 ...
The present study evaluated the efficacy of a novel highly specific test, an immunological RUT (IRUT), that uses a monoclonal antibody against H. pylori urease. Methods: The clinical evaluation of ...
However, the UBT detects all urease activity, whereas the IRUT specifically detects H. pylori-derived urease. The ROC analysis revealed that the two curves overlap considerably and that the two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback